About the Phenotypic Prevention Session
To find compounds like small molecules, peptides, or RNAi that change the phenotype of a cell or an organism in a desirable way, phenotypic screening is a sort of screening used in biological research and drug development. To understand how a phenotypic hit functions, phenotypic screening must be followed by identification and confirmation, frequently using chemoproteomics. Historically, medication discovery has been based on phenotypic screening. Compounds are tested in cellular or animal illness models to find those that result in a desired change in phenotype. The procedure of target deconvolution is used to identify the biological targets of chemicals only after they have been found. This comprehensive plan is known as target deconvolution. This overall strategy is referred to as "classical pharmacology", "forward pharmacology" or "phenotypic drug discovery" (PDD).
Topics Covered in Phenotypic Prevention
Phenotypic screening in drug discovery
Cell-based and organism disease models
Target deconvolution and hit identification
Chemoproteomics and mechanism-of-action studies
High-content imaging and assay design
Small molecule, peptide and RNAi libraries
Featured Speakers — Phenotypic Prevention 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Phenotypic Prevention Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Phenotypic Prevention Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Phenotypic Prevention work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Phenotypic Prevention research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Phenotypic Prevention track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Phenotypic Prevention Conference 2027 — FAQs
What is the Phenotypic Prevention track at IPHC 2027?
The Phenotypic Prevention track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Phenotypic Prevention. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Phenotypic Prevention sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Phenotypic Prevention are all welcome — whether presenting or attending.
Can I present my research in the Phenotypic Prevention track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Phenotypic Prevention sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Phenotypic Prevention track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.